Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain
- PMID: 12600206
- DOI: 10.1021/bi026635n
Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain
Abstract
The p53 DNA binding domain (DBD) contains a single bound zinc ion that is essential for activity. Zinc remains bound to wild-type DBD at temperatures below 30 degrees C; however, it rapidly dissociates at physiological temperature. The resulting zinc-free protein (apoDBD) is folded and stable. NMR spectra reveal that the DNA binding surface is altered in the absence of Zn(2+). Fluorescence anisotropy studies show that Zn(2+) removal abolishes site-specific DNA binding activity, although full nonspecific DNA binding affinity is retained. Surprisingly, the majority of tumorigenic mutations that destabilize DBD do not appreciably destabilize apoDBD. The R175H mutation instead substantially accelerates the rate of Zn(2+) loss. A considerable fraction of cellular p53 may therefore exist in the folded zinc-free form, especially when tumorigenic mutations are present. ApoDBD appears to promote aggregation of zinc-bound DBD via a nucleation-growth process. These data provide an explanation for the dominant negative phenotype exhibited by many mutations. Through a combination of induced p53 aggregation and diminished site-specific DNA binding activity, Zn(2+) loss may represent a significant inactivation pathway for p53 in the cell.
Similar articles
-
Zn(2+)-dependent misfolding of the p53 DNA binding domain.Biochemistry. 2007 Mar 13;46(10):2630-9. doi: 10.1021/bi062106y. Epub 2007 Feb 13. Biochemistry. 2007. PMID: 17297920
-
Folding and misfolding mechanisms of the p53 DNA binding domain at physiological temperature.Protein Sci. 2006 Nov;15(11):2457-65. doi: 10.1110/ps.062324206. Epub 2006 Sep 25. Protein Sci. 2006. PMID: 17001034 Free PMC article.
-
Effect of Zn2+ on DNA recognition and stability of the p53 DNA-binding domain.Biochemistry. 2006 Jun 20;45(24):7483-92. doi: 10.1021/bi0603165. Biochemistry. 2006. PMID: 16768444
-
The missing zinc: p53 misfolding and cancer.Metallomics. 2010 Jul;2(7):442-9. doi: 10.1039/c003915b. Epub 2010 May 18. Metallomics. 2010. PMID: 21072344 Review.
-
New insights into p53 function from structural studies.Oncogene. 1996 Apr 4;12(7):1379-85. Oncogene. 1996. PMID: 8622853 Review.
Cited by
-
A Novel In Vitro CypD-Mediated p53 Aggregation Assay Suggests a Model for Mitochondrial Permeability Transition by Chaperone Systems.J Mol Biol. 2016 Oct 9;428(20):4154-4167. doi: 10.1016/j.jmb.2016.08.001. Epub 2016 Aug 8. J Mol Biol. 2016. PMID: 27515399 Free PMC article.
-
Network Analysis of Molecular Dynamics Sectors in the p53 Protein.ACS Omega. 2022 Dec 20;8(1):571-587. doi: 10.1021/acsomega.2c05635. eCollection 2023 Jan 10. ACS Omega. 2022. PMID: 36643471 Free PMC article.
-
Therapeutics Targeting p53-MDM2 Interaction to Induce Cancer Cell Death.Int J Mol Sci. 2022 Apr 30;23(9):5005. doi: 10.3390/ijms23095005. Int J Mol Sci. 2022. PMID: 35563397 Free PMC article. Review.
-
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation.NPJ Breast Cancer. 2019 Apr 15;5:14. doi: 10.1038/s41523-019-0110-1. eCollection 2019. NPJ Breast Cancer. 2019. PMID: 30993195 Free PMC article.
-
Cellular zinc status alters chromatin accessibility and binding of transcription factor p53 to genomic sites.bioRxiv [Preprint]. 2023 Nov 21:2023.11.20.567954. doi: 10.1101/2023.11.20.567954. bioRxiv. 2023. Update in: Life Sci Alliance. 2024 Jul 5;7(9):e202402638. doi: 10.26508/lsa.202402638. PMID: 38045276 Free PMC article. Updated. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous